Nobabelle Cala (Ethinylestradiol, Gestodene)

Ethinylestradiol / Gestodene, the active ingredients in Nobabelle Cala, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Nobabelle Cala as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Nobabelle Cala, a combined oral contraceptive, is used to manage reproductive health by providing hormonal regulation.

Prevention of pregnancy: provides reliable contraception for women of child‑bearing potential. Menstrual cycle regulation: helps establish predictable monthly bleeding patterns. Acne improvement: reduces androgen‑driven skin lesions in some users. Management of endometriosis symptoms: suppresses ovarian hormone production to alleviate pelvic pain.

Nobabelle Cala may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Nausea or mild gastrointestinal upset. - Breast tenderness or enlargement. - Headache or migraine. - Weight gain or fluid retention. - Mood swings or irritability. - Breakthrough or spotting bleeding.

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism). - Arterial thrombosis (stroke, myocardial infarction). - Severe hypertension or hypertensive crisis. - Liver adenoma or other hepatic tumors. - Anaphylactic or severe allergic reactions. - Visual disturbances or sudden loss of vision.

Before prescribing Nobabelle Cala, clinicians should consider several precautionary measures to ensure safe use.

Smoking: avoid use in women over 35 who smoke, due to increased thrombotic risk. History of thromboembolism: contraindicated in patients with prior venous or arterial clotting events. Pregnancy: discontinue immediately if pregnancy is confirmed. Liver disease: use with caution in active liver disease or hepatic tumors. Hypertension: monitor blood pressure regularly in patients with elevated readings. Store at ambient temperature: keep tablets below 25 °C in the original packaging, protected from moisture.

Nobabelle Cala can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) that reduce hormonal levels. - Rifampicin or other potent inducers of CYP3A4, which may diminish contraceptive effect. - St. John's wort, a herbal inducer that can lead to contraceptive failure.

Moderate Interactions (Monitor Closely): - Certain antifungals (e.g., ketoconazole) that may increase hormone concentrations. - Macrolide antibiotics (e.g., erythromycin) that can modestly raise plasma levels. - Lithium, where hormonal changes may affect lithium clearance and toxicity risk.